Pharma news
Americas
The US Chamber of Commerce has urged the Canadian government to address its ‘promise utility doctrine’, claiming that it “dramatically undermines legal certainty for medical innovators in Canada”. 23 March 2017
Americas
A Biogen patent covering the drug Tecfidera has been upheld by the Patent Trial and Appeal Board, after a challenge from Kyle Bass’s Coalition for Affordable Drugs. 23 March 2017
Pharma
The English High Court has ruled that a supplementary protection certificate owned by Merck Sharp & Dohme is invalid because it didn’t comply with European regulations. 23 March 2017
Americas
Sanofi and Regeneron have filed a declaratory judgment of non-infringement claiming that their product Dupixent does not infringe a patent belonging to Amgen. 22 March 2017
Americas
The Canadian government has won nearly $5 million in an arbitration claim filed by Eli Lilly which alleged wrongful termination of its drug patents. 21 March 2017
Pharma
There have been two significant references on issues that have been "left hanging" by the Court of Justice of the European Union in the last spate of decisions, says Paul England, senior associate at Taylor Wessing, in a video interview with LSIPR. 21 March 2017
Americas
Biotech company Pacific Biosciences, of California, has filed a complaint against UK-based Oxford Nanopore Technologies for alleged patent infringement. 17 March 2017
Americas
AstraZeneca and Zydus Pharmaceuticals have entered into a settlement agreement over a patent dispute centring on heartburn drug Nexium. 17 March 2017
Americas
Dow Pharmaceutical Sciences and Valeant Pharmaceuticals have sued Teva and its subsidiary Actavis for patent infringement of Onexton (clindamycin phosphate and benzoyl peroxide), a treatment for acne. 16 March 2017
Americas
President Trump’s decision to pull the US out of the Trans-Pacific Partnership trade deal may have particularly pernicious consequences for the pharmaceutical and biotechnology industries, writes Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff. 15 March 2017